A Study to Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy
Clinical trial NCT06006585 · COMPLETED
Trial details
- NCT number
- NCT06006585
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-06
- Primary completion
- 2024-05-24
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.